50242-087Level 3
KADCYLA (ADO-TRASTUZUMAB EMTANSINE)
**Product type:** Human Prescription Drug
**Active ingredient:** TRASTUZUMAB EMTANSINE
**Strength:** 20 mg/mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA125427)
GET
/api/v1/systems/ndc_fda/nodes/50242-087Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.